Abtak Logo

non-alcoholic-fatty-liver-disease News

Stay updated with the latest non-alcoholic-fatty-liver-disease news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on non-alcoholic-fatty-liver-disease topics.

Unknown Source - Business - News Image
source image
BusinessAug 14, 2025 10:51 AM

Shilpa Medicare's NorUDCA Makes History as First Approved NAFLD Therapy Worldwide

Raichur (Karnataka) [India], August 14: In a landmark moment for global hepatology and Indian pharmaceutical innovation, Shilpa Medicare Limited (BSE: 530661) (NSE: SHILPAMED) has secured the world first regulatory approval from India Central Drugs Standard Control Organization (CDSCO) for Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 mg, the first-ever approved therapy targeting NAFLD. * Shilpa Medicare emerges as the global pioneer to receive approval for NorUDCA, offering new hope to over a ...Read More >

LatestLY - Business - News Image
soure image
14
BusinessAug 14, 2025 10:31 AM

Business News | Shilpa Medicare's NorUDCA Makes History as First Approved NAFLD Therapy Worldwide | ...

Raichur (Karnataka) [India], August 14: In a landmark moment for global hepatology and Indian pharmaceutical innovation, Shilpa Medicare Limited (BSE: 530661) (NSE: SHILPAMED) has secured the world's first regulatory approval from India's Central Drugs Standard Control Organization (CDSCO) for Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 mg, the first-ever approved therapy targeting NAFLD. Also Read | 'Coolie' X Review: Rajinikanth's 'One-Man Show' With Nagarjuna's Stylish Act and Anirudh Rav ...Read More >

News Nation English - Politics Business - News Image
soure image
30
PoliticsBusinessAug 14, 2025 10:20 AM

Shilpa Medicare's NorUDCA Makes History as First Approved NAFLD Therapy Worldwide

Raichur (Karnataka) [India], August 14: In a landmark moment for global hepatology and Indian pharmaceutical innovation, Shilpa Medicare Limited (BSE: 530661) (NSE: SHILPAMED) has secured the world first regulatory approval from India Central Drugs Standard Control Organization (CDSCO) for Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 mg, the first-ever approved therapy targeting NAFLD. * Shilpa Medicare emerges as the global pioneer to receive approval for NorUDCA, offering new hope to over a ...Read More >

The Times of India - Health - News Image
soure image
16
HealthJul 14, 2025 05:15 AM

Experts raise alarm as study finds 29% city kids overweight or obese | Lucknow News - Times of India

Lucknow: Childhood obesity is emerging as a major health concern in the city, with doctors warning that it is leading to serious metabolic complications at an early age.The issue was raised by experts at a recent event held at a private hotel. They highlighted a study published in the International Journal of Research and Review (2024), which revealed that 29.7% of children aged 6-12 in Lucknow are either overweight or obese -- nearly three times the national average of 8.4%.The study, titled, " ...Read More >

Jammu Kashmir Latest News | Tourism | Breaking News J&K - Other Politics Business Health Entertainment - News Image
soure image
18

Indian fertilizer firms sign pacts for yearly import of 3.1 mn MT of DAP from Saudi

Three Indian fertilizer companies -- IPL, KRIBHCO and Coromandel -- have signed agreements with Ma'aden, the Saudi Arabian major, for importing 3.1 million metric tonnes of Diammonium Phosphate (DAP) per annum for five years from 2025-26. The agreements were signed during Chemicals and Fertilizers Minister JP Nadda's visit to Dammam and Riyadh between July 11 [...] Three Indian fertilizer companies -- IPL, KRIBHCO and Coromandel -- have signed agreements with Ma'aden, the Saudi Arabian major, f ...Read More >

The New Indian Express - Health - News Image
soure image
23
HealthJul 02, 2025 08:10 AM

Five-km daily walk, half-plate meal can reverse nonalcoholic fatty liver disease: Study

BHUBANESWAR: Not expensive medications, just a brisk 5-km daily walk and half-plate meal at lunch-dinner can significantly reverse nonalcoholic fatty liver disease (NAFLD) within a short period, a landmark study from Odisha has established. While NAFLD, a major precursor of serious diseases like liver cancer and cirrhosis, has emerged a leading public health problem in the country over the recent years, the study has challenged the growing dependence on medications for its treatment. Led by em ...Read More >

Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.